Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
about
Allergen Immunotherapy: Past, Present, and FutureT Cell Epitope Peptide Therapy for Allergic DiseasesImmunoregulatory T cell epitope peptides: the new frontier in allergy therapyAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyMolecular approach to allergy diagnosis and therapyMolecular biomarkers for grass pollen immunotherapy.Recombinant allergens for pollen immunotherapy.Immunotherapy in allergy and cellular tests: state of art.Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.Modified allergens and their potential to treat allergic disease.Allergen immunotherapy for birch pollen-allergic patients: recent advances.Novel approaches and perspectives in allergen immunotherapy.Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.Therapeutic vaccines for allergic disease.Perspectives in allergen immunotherapy: 2017 and beyond.Next generation immunotherapy for tree pollen allergies.A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.Immunotherapy with B cell epitopes ameliorates inflammatory responses in Balb/c mice.[Innovative forms of specific immunotherapy].
P2860
Q26765974-1CE44A73-9C85-44AC-B5DB-A0B4BECAF50AQ26771989-6E98AE82-3AEC-4582-AFB0-A5D9D0032052Q26822702-7A7891FF-0E97-40FB-9AD0-FFFD9A8D6357Q26852113-9F21A10A-1A8F-4BB3-8E1A-9E3EEE4F3FEBQ33822511-112C36F6-F5DE-4C0D-B783-9A58A03A78E3Q34093047-748F09EB-CE4F-492A-9EDA-8D288715A12AQ38166829-D079BC71-5163-4B41-AB76-92104959C6F5Q38203380-43762345-C62C-42A9-95BB-5723E2203B05Q38217708-DC075480-2A4F-44FF-AEA9-CF49F85D1410Q38255585-911A684A-2320-4875-A1E7-3892B289EC22Q38824177-E2BC1D74-02F1-4DF1-A7B6-9808701481A0Q39103046-2350E04D-F099-4A10-B552-253C3610E121Q40087434-E31F03E1-21D3-4987-A8E7-01C676A77BA2Q46198561-96E4F6EC-424A-4EE0-B458-B9163AAE4B9CQ47100584-D87EBBAE-B22A-42BD-A06E-CA1FD4DCCE07Q47700986-9714C6D4-453A-428B-AC59-60518B9C7462Q47884083-5DD31DBA-4485-40ED-A196-5CD34A95CFB7Q48278642-7A24C067-D0AD-4195-BBA2-CEE42913FD54Q51533953-BF3CA383-ADF1-4312-9574-5519FC5D9A4DQ51702685-AB2344B3-1319-4E52-914A-0188891F015FQ53505747-B717695A-C6AE-4107-A6B3-BD62F1447046
P2860
Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel birch pollen specific im ...... ontiguous overlapping peptides
@en
type
label
Novel birch pollen specific im ...... ontiguous overlapping peptides
@en
prefLabel
Novel birch pollen specific im ...... ontiguous overlapping peptides
@en
P2093
P2860
P356
P1476
Novel birch pollen specific im ...... ontiguous overlapping peptides
@en
P2093
Anne-Christine Thierry
Caroline Boudousquié
Christophe Reymond
Céline Pellaton
François Spertini
Jacqueline Wassenberg
Nathalie Barbier
Régine Audran
Yannick Perrin
P2860
P2888
P356
10.1186/2045-7022-3-17
P577
2013-06-01T00:00:00Z
P5875
P6179
1041705396